Cargando…
The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials
BACKGROUND: Ascites is the most common complication of cirrhosis. It may lead to the consequence of poor prognosis and the deterioration of quality of life. Asopressin V2 receptor antagonists is a kind of vaptans, and it has been proved to be effective in hyponatremia patients. We conducted a meta-a...
Autores principales: | Yan, Long, Xie, Feng, Lu, Jiongjiong, Ni, Qingqiang, Shi, Changying, Tang, Caixi, Yang, Jiamei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460759/ https://www.ncbi.nlm.nih.gov/pubmed/26054761 http://dx.doi.org/10.1186/s12876-015-0297-z |
Ejemplares similares
-
Vasopressin and Vasopressin Receptor Antagonists
por: Oh, Yun Kyu
Publicado: (2008) -
Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V(2)-Receptor Antagonist Tolvaptan
por: Gaglio, Paul, et al.
Publicado: (2012) -
Effects of Nucleoside Analogue on Patients with Chronic Hepatitis B-Associated Liver Failure: Meta-Analysis
por: Xie, Feng, et al.
Publicado: (2013) -
Vasopressin receptor antagonists and their role in clinical medicine
por: Narayen, Girish, et al.
Publicado: (2012) -
Hyponatremia: A role for vasopressin receptor antagonists?
por: Ramesh, Gourishankar
Publicado: (2018)